Glucose control continues to be challenging for intensivists, in particular in high-risk neonates. Many factors play a role in glucose regulation including intrinsic and extrinsic factors. Optimal targets for euglycemia are debatable with uncertain short and long-term effects. Glucose measurement technology has continued to advance over the past decade; unfortunately, the availability of these advanced devices outside of research continues to be problematic. Treatment approaches should be individualized depending on etiology, symptoms, and neonatal conditions. Glucose infusions should be titrated based upon variations in organ glucose uptake, co-morbidities and postnatal development. In this article we summarize the most common dilemmas encountered in the NICU: ranges for euglycemia, physiological differences, approach for glucose measurements, monitoring and best strategies to control parenteral glucose delivery.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167:238–45.
Harris DL, Weston PJ, Gamble GD, Harding JE. Glucose Profiles in Healthy Term Infants in the First 5 Days: The Glucose in Well Babies (GLOW) Study. J Pediatr. 2020;223:34–41.e4.
Adamkin DH. Committee on fetus and newborn. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127:575–9.
Sinclair JC. Approaches to the definition of neonatal hypoglycemia. Acta Paediatr Jpn Overseas Ed. 1997;39:S17–20.
Rozance PJ, Hay WW. Hypoglycemia in newborn infants: features associated with adverse outcomes. Biol Neonate. 2006;90:74–86.
van Kempen AAMW, Eskes PF, Nuytemans DHGM, van der Lee JH, Dijksman LM, van Veenendaal NR, et al. Lower versus traditional treatment threshold for neonatal hypoglycemia. N. Engl J Med. 2020;382:534–44.
Zhang J, Shi W, Chen C. Neonatal glycogen storage disease Ia. Pediatr Neonatol. 2015;56:66–7.
Blanco CL, Kim J. Neonatal glucose homeostasis. Clin Perinatol. 2022;49:393–404.
Beardsall K. Measurement of glucose levels in the newborn. Early Hum Dev. 2010;86:263–7.
Wang L, Sievenpiper JL, de Souza RJ, Thomaz M, Blatz S, Grey V, et al. Hematocrit correction does not improve glucose monitor accuracy in the assessment of neonatal hypoglycemia. Clin Chem Lab Med. 2013;51:1627–35.
Balion C, Grey V, Ismaila A, Blatz S, Seidlitz W. Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatr. 2006;6:28.
Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther. 2009;11:S11–16.
Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med. 2000;124:1135–40.
Ho HT, Yeung WKY, Young BWY. Evaluation of “point of care” devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal Ed. 2004;89:F356–359.
St-Louis P, Ethier J. An evaluation of three glucose meter systems and their performance in relation to criteria of acceptability for neonatal specimens. Clin Chim Acta. 2002;322:139–48.
Woo HC, Tolosa L, El-Metwally D, Viscardi RM. Glucose monitoring in neonates: need for accurate and non-invasive methods. Arch Dis Child Fetal Neonatal Ed. 2014;99:F153–157.
Jangam SR, Hayter G, Dunn TC. Impact of glucose measurement processing delays on clinical accuracy and relevance. J Diabetes Sci Technol. 2013;7:660–8.
Howanitz PJ, Cembrowski GS, Steindel SJ, Long TA. Physician goals and laboratory test turnaround times. A College of American Pathologists Q-Probes study of 2763 clinicians and 722 institutions. Arch Pathol Lab Med. 1993;117:22–8.
Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem. 1998;44:1597–603.
Lee-Lewandrowski E, Corboy D, Lewandrowski K, Sinclair J, McDermot S, Benzer TI. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med. 2003;127:456–60.
Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994;40:1628–30.
McKinlay CJD, Chase JG, Dickson J, Harris DL, Alsweiler JM, Harding JE. Continuous glucose monitoring in neonates: a review. Matern Health Neonatol Perinatol. 2017;3:18.
Shah R, McKinlay CJD, Harding JE. Neonatal hypoglycemia: continuous glucose monitoring. Curr Opin Pediatr. 2018;30:204–8.
Saw HP, Yao NW, Chiu CD, Chen JY. The value of real-time continuous glucose monitoring in premature infants of diabetic mothers. PloS One. 2017;12:e0186486.
Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N. Engl J Med. 2013;368:824–33.
Beardsall K, Thomson L, Guy C, Bond S, Allison A, Pantaleo B, et al. Continuous glucose monitoring in extremely preterm infants in intensive care: the REACT RCT and pilot study of ‘closed-loop’ technology. Southampton (UK): NIHR Journals Library. 2021. Accessed 8 Jul 2022. (Efficacy and Mechanism Evaluation). http://www.ncbi.nlm.nih.gov/books/NBK574813/.
Uettwiller F, Chemin A, Bonnemaison E, Favrais G, Saliba E, Labarthe F. Real-time continuous glucose monitoring reduces the duration of hypoglycemia episodes: a randomized trial in very low birth weight neonates. PloS One. 2015;10:e0116255.
Galderisi A, Facchinetti A, Steil GM, Ortiz-Rubio P, Cavallin F, Tamborlane WV, et al. Continuous glucose monitoring in very preterm infants: a randomized controlled trial. Pediatrics. 2017;140:e20171162.
Thomson L, Elleri D, Bond S, Howlett J, Dunger DB, Beardsall K. Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring. Arch Dis Child Fetal Neonatal Ed. 2019;104:F353–9.
McKinlay CJD, Alsweiler JM, Anstice NS, Burakevych N, Chakraborty A, Chase JG, et al. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr. 2017;171:972–83.
Lilien LD, Pildes RS, Srinivasan G, Voora S, Yeh TF. Treatment of neonatal hypoglycemia with minibolus and intraveous glucose infusion. J Pediatr. 1980;97:295–8.
McGill-Vargas L, Gastaldelli A, Liang H, Anzueto Guerra D, Johnson-Pais T, Seidner S, et al. Hepatic Insulin resistance and altered gluconeogenic pathway in premature baboons. Endocrinology. 2017;158:1140–51.
Blanco CL, McGill-Vargas LL, Gastaldelli A, Seidner SR, McCurnin DC, Leland MM, et al. Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons. Endocrinology. 2015;156:813–23.
Blanco CL, Baillargeon JG, Morrison RL, Gong AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol J Calif Perinat Assoc. 2006;26:737–41.
Alexandrou G, Skiöld B, Karlén J, Tessma MK, Norman M, Adén U, et al. Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants. Pediatrics. 2010;125:e584–591.
Callaway DA, McGill-Vargas LL, Quinn A, Jordan JL, Winter LA, Anzueto D, et al. Prematurity disrupts glomeruli development, whereas prematurity and hyperglycemia lead to altered nephron maturation and increased oxidative stress in newborn baboons. Pediatr Res. 2018;83:702–11.
Kermorvant-Duchemin E, Pinel AC, Lavalette S, Lenne D, Raoul W, Calippe B, et al. Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina. PloS One. 2013;8:e79545.
Ramel S, Rao R. Hyperglycemia in extremely preterm infants. NeoReviews. 2020;21:e89–97.
Burgess L, Morgan C, Mayes K, Tan M. Plasma arginine levels and blood glucose control in very preterm infants receiving 2 different parenteral nutrition regimens. JPEN J Parenter Enter Nutr. 2014;38:243–53.
Chong E, Yosypiv IV. Developmental programming of hypertension and kidney disease. Int J Nephrol. 2012;2012:1–15.
Quinn AR, Blanco CL, Perego C, Finzi G, La Rosa S, Capella C, et al. The ontogeny of the endocrine pancreas in the fetal/newborn baboon. J Endocrinol. 2012;214:289–99.
Chertok IRA, Raz I, Shoham I, Haddad H, Wiznitzer A. Effects of early breastfeeding on neonatal glucose levels of term infants born to women with gestational diabetes. J Hum Nutr Diet. 2009;22:166–9.
Harris DL, Gamble GD, Weston PJ, Harding JE. What happens to blood glucose concentrations after oral treatment for neonatal hypoglycemia? J Pediatr. 2017;190:136–41.
Maayan-Metzger A, Schushan-Eisen I, Lubin D, Moran O, Kuint J, Mazkereth R. Delivery room breastfeeding for prevention of hypoglycaemia in infants of diabetic mothers. Fetal Pediatr Pathol. 2014;33:23–8.
Pierro A, Nah SA. Surgical management of congenital hyperinsulinism of infancy. Semin Pediatr Surg. 2011;20:50–3.
Hegarty JE, Harding JE, Gamble GD, Crowther CA, Edlin R, Alsweiler JM. Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study). PLoS Med. 2016;13:e1002155.
Coors SM, Cousin JJ, Hagan JL, Kaiser JR. Prophylactic dextrose gel does not prevent neonatal hypoglycemia: a quasi-experimental pilot study. J Pediatr. 2018;198:156–61.
Harding JE, Hegarty JE, Crowther CA, Edlin RP, Gamble GD, Alsweiler JM, et al. Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): a multicenter, double-blind randomized controlled trial. PLoS Med. 2021;18:e1003411.
All data utilized in this review has been published and funding sources are detailed in each manuscript referenced.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Blanco, C.L., Smith, V., Ramel, S.E. et al. Dilemmas in parenteral glucose delivery and approach to glucose monitoring and interpretation in the neonate. J Perinatol (2023). https://doi.org/10.1038/s41372-023-01640-5